The Max Planck-Chinese Academy of Sciences (CAS) Center for Synthetic Biochemistry opened today in Shenzhen, marking a milestone in cross-border scientific collaboration. Established at the Shenzhen Institute of Advanced Technology (SIAT), the center is the first joint research initiative between Germany’s Max Planck Society (MPG) and CAS focused exclusively on advancing synthetic biology and biochemical engineering.
The facility aims to address global challenges such as sustainable energy production and precision medicine through engineered biological systems. Dr. Lena Weber, MPG’s director of international cooperation, stated, “This partnership combines Germany’s expertise in foundational research with China’s rapid innovation capabilities in applied sciences.”
CAS representatives highlighted the center’s role in fostering talent exchange programs and its alignment with China’s 2026 priorities in green biotechnology. Initial projects include developing enzyme-driven carbon capture technologies and AI-assisted metabolic pathway design.
With over 200 researchers from 15 countries, the center is poised to become a hub for Asia-Europe academic synergy. Analysts note its strategic location in Shenzhen’s innovation corridor could attract significant overseas investment in biotech startups.
